Rejuvenation Technologies Inc.
Rejuvenation Technologies Inc. is pioneering advanced cellular aging reversal technologies, including therapeutic telomere extension, to rewind cellular mechanisms of aging and treat age-related diseases. Their mission is to transform medicine by rewinding cellular aging clocks and enhancing cellular health.
Industries
Nr. of Employees
small (1-50)
Rejuvenation Technologies Inc.
Mountain View, California, United States, North America
Products
Telomerase activation therapy candidate for pulmonary fibrosis
An investigational therapy using transient telomerase activation delivered to lung cells to restore telomere length and address telomere-driven pulmonary disease.
Telomerase activation therapy candidate for chronic liver disease
An investigational therapy using transient telomerase activation delivered to liver cells to maintain telomere length and support liver function.
Telomerase activation therapy candidate for hematologic indications
An investigational therapy using transient telomerase activation delivered to hematopoietic cells to support blood cell production and address marrow failure related to short telomeres.
Telomerase activation therapy candidate for pulmonary fibrosis
An investigational therapy using transient telomerase activation delivered to lung cells to restore telomere length and address telomere-driven pulmonary disease.
Telomerase activation therapy candidate for chronic liver disease
An investigational therapy using transient telomerase activation delivered to liver cells to maintain telomere length and support liver function.
Telomerase activation therapy candidate for hematologic indications
An investigational therapy using transient telomerase activation delivered to hematopoietic cells to support blood cell production and address marrow failure related to short telomeres.
Services
Research collaborations
Collaborative preclinical and translational research partnerships with academic and industry groups to develop telomere-targeted therapies.
Clinical trial enrollment and information
Information and enrollment pathways for planned early-phase clinical trials evaluating transient telomerase activation therapies in specific disease indications.
Research collaborations
Collaborative preclinical and translational research partnerships with academic and industry groups to develop telomere-targeted therapies.
Clinical trial enrollment and information
Information and enrollment pathways for planned early-phase clinical trials evaluating transient telomerase activation therapies in specific disease indications.
Expertise Areas
- Telomere biology and therapeutics
- mRNA therapeutic development
- Nanoparticle-mediated delivery
- Preclinical translational research
Key Technologies
- Modified mRNA therapeutics
- Lipid nanoparticle delivery
- Telomerase activation
- Telomere length measurement assays